Trial Profile
Evaluation of Anti-biofilm Effects of Ferumoxytol (Feraheme) Using an in Situ Biofilm Demineralization Model
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 26 Sep 2018
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Iron deficiency anaemia; Peripheral arterial disorders
- Focus Pharmacodynamics
- 26 Sep 2018 New trial record